Horvath Lab Launches Groundbreaking Breast Cancer Transcriptome Study

Thanks to the generous support of the McCormick Endowment Fund, and in collaboration with Dr Pavani Chalassani, our team is thrilled to launch a first-of-its-kind study on full-cell transcriptome profiling of breast cancer using long-read single-cell RNA sequencing (scRNA-seq) technology. 

This pilot represents a major advance in resolving isoform complexity and mutation-linked expression signatures at single-cell resolution, linking genomic variation and functional cellular states.